ID   HCST_HUMAN              Reviewed;          93 AA.
AC   Q9UBK5; Q9UBS1; Q9Y3Y0;
DT   29-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   15-MAR-2017, entry version 116.
DE   RecName: Full=Hematopoietic cell signal transducer;
DE   AltName: Full=DNAX-activation protein 10;
DE   AltName: Full=Membrane protein DAP10;
DE   AltName: Full=Transmembrane adapter protein KAP10;
DE   Flags: Precursor;
GN   Name=HCST; Synonyms=DAP10, KAP10, PIK3AP; ORFNames=UNQ587/PRO1157;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   INTERACTION WITH PIK3R1 AND GRB2, AND PHOSPHORYLATION.
RX   PubMed=10528161;
RA   Chang C., Dietrich J., Harpur A.G., Lindquist J.A., Haude A.,
RA   Loke Y.W., King A., Colonna M., Trowsdale J., Wilson M.J.;
RT   "KAP10, a novel transmembrane adapter protein genetically linked to
RT   DAP12 but with unique signaling properties.";
RL   J. Immunol. 163:4651-4654(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, INTERACTION
RP   WITH KLRK1 AND PIK3R1, GLYCOSYLATION, SUBCELLULAR LOCATION,
RP   PHOSPHORYLATION, AND MUTAGENESIS OF ASP-57.
RX   PubMed=10426994; DOI=10.1126/science.285.5428.730;
RA   Wu J., Song Y., Bakker A.B.H., Bauer S., Spies T., Lanier L.L.,
RA   Phillips J.H.;
RT   "An activating immunoreceptor complex formed by NKG2D and DAP10.";
RL   Science 285:730-732(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=11398969; DOI=10.1007/s002510100321;
RA   Yim D., Jie H.-B., Sotiriadis J., Kim Y.-S., Kim K.-S.,
RA   Rothschild M.F., Lanier L.L., Kim Y.B.;
RT   "Molecular cloning and characterization of pig immunoreceptor DAP10
RT   and NKG2D.";
RL   Immunogenetics 53:243-249(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH KLRK1.
RX   PubMed=11015446; DOI=10.1084/jem.192.7.1059;
RA   Wu J., Cherwinski H., Spies T., Phillips J.H., Lanier L.L.;
RT   "DAP10 and DAP12 form distinct, but functionally cooperative, receptor
RT   complexes in natural killer cells.";
RL   J. Exp. Med. 192:1059-1068(2000).
RN   [8]
RP   FUNCTION.
RX   PubMed=11777960; DOI=10.4049/jimmunol.168.2.671;
RA   Sutherland C.L., Chalupny N.J., Schooley K., VandenBos T., Kubin M.,
RA   Cosman D.;
RT   "UL16-binding proteins, novel MHC class I-related proteins, bind to
RT   NKG2D and activate multiple signaling pathways in primary NK cells.";
RL   J. Immunol. 168:671-679(2002).
RN   [9]
RP   FUNCTION.
RX   PubMed=12740575; DOI=10.1038/ni929;
RA   Billadeau D.D., Upshaw J.L., Schoon R.A., Dick C.J., Leibson P.J.;
RT   "NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-
RT   independent regulatory pathway.";
RL   Nat. Immunol. 4:557-564(2003).
RN   [10]
RP   FUNCTION.
RX   PubMed=12740576; DOI=10.1038/ni930;
RA   Zompi S., Hamerman J.A., Ogasawara K., Schweighoffer E.,
RA   Tybulewicz V.L.J., Di Santo J.P., Lanier L.L., Colucci F.;
RT   "NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk
RT   family kinases.";
RL   Nat. Immunol. 4:565-572(2003).
RN   [11]
RP   INTERACTION WITH KLRK1.
RX   PubMed=15294961; DOI=10.4049/jimmunol.173.4.2470;
RA   Rosen D.B., Araki M., Hamerman J.A., Chen T., Yamamura T.,
RA   Lanier L.L.;
RT   "A Structural basis for the association of DAP12 with mouse, but not
RT   human, NKG2D.";
RL   J. Immunol. 173:2470-2478(2004).
RN   [12]
RP   FUNCTION.
RX   PubMed=16002667; DOI=10.4049/jimmunol.175.2.720;
RA   Wiemann K., Mittruecker H.-W., Feger U., Welte S.A., Yokoyama W.M.,
RA   Spies T., Rammensee H.-G., Steinle A.;
RT   "Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in
RT   vivo.";
RL   J. Immunol. 175:720-729(2005).
RN   [13]
RP   FUNCTION.
RX   PubMed=16339517; DOI=10.4049/jimmunol.175.12.7819;
RA   Karimi M., Cao T.M., Baker J.A., Verneris M.R., Soares L.,
RA   Negrin R.S.;
RT   "Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of
RT   activated CD8+ T cells and NK cells.";
RL   J. Immunol. 175:7819-7828(2005).
RN   [14]
RP   SUBUNIT.
RX   PubMed=15894612; DOI=10.1073/pnas.0502439102;
RA   Garrity D., Call M.E., Feng J., Wucherpfennig K.W.;
RT   "The activating NKG2D receptor assembles in the membrane with two
RT   signaling dimers into a hexameric structure.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:7641-7646(2005).
RN   [15]
RP   INDUCTION.
RX   PubMed=16424177; DOI=10.4049/jimmunol.176.3.1490;
RA   Burgess S.J., Marusina A.I., Pathmanathan I., Borrego F.,
RA   Coligan J.E.;
RT   "IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T
RT   cells.";
RL   J. Immunol. 176:1490-1497(2006).
RN   [16]
RP   FUNCTION, INTERACTION WITH GRB2-VAV1 AND PIK3R1, PHOSPHORYLATION AT
RP   TYR-86, AND MUTAGENESIS OF ASN-88 AND MET-89.
RX   PubMed=16582911; DOI=10.1038/ni1325;
RA   Upshaw J.L., Arneson L.N., Schoon R.A., Dick C.J., Billadeau D.D.,
RA   Leibson P.J.;
RT   "NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1
RT   intermediate and phosphatidylinositol-3-kinase in human natural killer
RT   cells.";
RL   Nat. Immunol. 7:524-532(2006).
RN   [17]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=18097042; DOI=10.4049/jimmunol.180.1.409;
RA   Marusina A.I., Burgess S.J., Pathmanathan I., Borrego F.,
RA   Coligan J.E.;
RT   "Regulation of human DAP10 gene expression in NK and T cells by Ap-1
RT   transcription factors.";
RL   J. Immunol. 180:409-417(2008).
CC   -!- FUNCTION: Transmembrane adapter protein which associates with
CC       KLRK1 to form an activation receptor KLRK1-HCST in lymphoid and
CC       myeloid cells; this receptor plays a major role in triggering
CC       cytotoxicity against target cells expressing cell surface ligands
CC       such as MHC class I chain-related MICA and MICB, and UL16-binding
CC       proteins (ULBPs); these ligands are up-regulated by stress
CC       conditions and pathological state such as viral infection and
CC       tumor transformation. Functions as docking site for PI3-kinase
CC       PIK3R1 and GRB2. Interaction of ULBPs with KLRK1-HCST triggers
CC       calcium mobilization and activation of the PIK3R1, MAP2K/ERK, and
CC       JAK2/STAT5 signaling pathways. Both PIK3R1 and GRB2 are required
CC       for full KLRK1-HCST-mediated activation and ultimate killing of
CC       target cells. In NK cells, KLRK1-HCST signaling directly induces
CC       cytotoxicity and enhances cytokine production initiated via
CC       DAP12/TYROBP-associated receptors. In T-cells, it provides
CC       primarily costimulation for TCR-induced signals. KLRK1-HCST
CC       receptor plays a role in immune surveillance against tumors and is
CC       required for cytolysis of tumors cells; indeed, melanoma cells
CC       that do not express KLRK1 ligands escape from immune surveillance
CC       mediated by NK cells. {ECO:0000269|PubMed:10426994,
CC       ECO:0000269|PubMed:10528161, ECO:0000269|PubMed:11015446,
CC       ECO:0000269|PubMed:11777960, ECO:0000269|PubMed:12740575,
CC       ECO:0000269|PubMed:12740576, ECO:0000269|PubMed:16002667,
CC       ECO:0000269|PubMed:16339517, ECO:0000269|PubMed:16582911,
CC       ECO:0000269|PubMed:18097042}.
CC   -!- SUBUNIT: Interacts with CLEC5A (By similarity). Forms an
CC       CLEC5A/TYROBP/HCST trimolecular complex depending almost solely on
CC       TYROBP (By similarity). Homodimer; Disulfide-linked. Heterohexamer
CC       composed of four subunits of HCST/DAP10 and two subunits of KLRK1.
CC       Interacts (via transmembrane domain) with KLRK1 (via transmembrane
CC       domain); the interaction is required for KLRK1 NK cell surface and
CC       induces NK cell-mediated cytotoxicity. Interacts with PIK3R1 and
CC       GRB2. {ECO:0000250, ECO:0000269|PubMed:10426994,
CC       ECO:0000269|PubMed:10528161, ECO:0000269|PubMed:11015446,
CC       ECO:0000269|PubMed:15294961, ECO:0000269|PubMed:15894612,
CC       ECO:0000269|PubMed:16582911}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:10426994};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:10426994}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UBK5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UBK5-2; Sequence=VSP_033022;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in hemopoietic cells
CC       such as NK cells, subset of T-cells and monocytes. Detected in
CC       leukocytes, spleen, and thymus. {ECO:0000269|PubMed:10528161}.
CC   -!- INDUCTION: By T-cell receptor (TCR) ligation, which leads to
CC       enhanced KLRK1-HCST cell surface expression. Down-regulated by
CC       IL21/interleukin-21 in T-cells and NK cells.
CC       {ECO:0000269|PubMed:16424177, ECO:0000269|PubMed:18097042}.
CC   -!- PTM: Phosphorylated; PIK3R1 and GRB2 associate specifically with
CC       tyrosine-phosphorylated HCST. {ECO:0000269|PubMed:10426994,
CC       ECO:0000269|PubMed:10528161, ECO:0000269|PubMed:16582911}.
CC   -!- PTM: O-glycosylated. {ECO:0000269|PubMed:10426994}.
CC   -!- MISCELLANEOUS: Silencing of HCST suppresses cytolytic activity of
CC       T-cells and NK cells.
CC   -!- SIMILARITY: Belongs to the DAP10 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF172929; AAD50293.1; -; mRNA.
DR   EMBL; AF072844; AAD46986.1; -; mRNA.
DR   EMBL; AF072845; AAD46987.1; -; Genomic_DNA.
DR   EMBL; AF122904; AAD47911.1; -; mRNA.
DR   EMBL; AF285447; AAG29425.1; -; mRNA.
DR   EMBL; AY359058; AAQ89417.1; -; mRNA.
DR   EMBL; AL050163; CAB43303.2; -; mRNA.
DR   EMBL; BC035931; AAH35931.1; -; mRNA.
DR   EMBL; BC046348; AAH46348.1; -; mRNA.
DR   EMBL; BC065224; AAH65224.1; -; mRNA.
DR   CCDS; CCDS32998.1; -. [Q9UBK5-1]
DR   CCDS; CCDS46057.1; -. [Q9UBK5-2]
DR   PIR; T08788; T08788.
DR   RefSeq; NP_001007470.1; NM_001007469.1. [Q9UBK5-2]
DR   RefSeq; NP_055081.1; NM_014266.3. [Q9UBK5-1]
DR   UniGene; Hs.117339; -.
DR   ProteinModelPortal; Q9UBK5; -.
DR   SMR; Q9UBK5; -.
DR   BioGrid; 116079; 3.
DR   IntAct; Q9UBK5; 2.
DR   STRING; 9606.ENSP00000246551; -.
DR   iPTMnet; Q9UBK5; -.
DR   PhosphoSitePlus; Q9UBK5; -.
DR   BioMuta; HCST; -.
DR   DMDM; 74734930; -.
DR   PaxDb; Q9UBK5; -.
DR   PeptideAtlas; Q9UBK5; -.
DR   PRIDE; Q9UBK5; -.
DR   Ensembl; ENST00000246551; ENSP00000246551; ENSG00000126264. [Q9UBK5-1]
DR   Ensembl; ENST00000437550; ENSP00000400516; ENSG00000126264. [Q9UBK5-2]
DR   GeneID; 10870; -.
DR   KEGG; hsa:10870; -.
DR   UCSC; uc002ock.2; human. [Q9UBK5-1]
DR   CTD; 10870; -.
DR   DisGeNET; 10870; -.
DR   GeneCards; HCST; -.
DR   HGNC; HGNC:16977; HCST.
DR   HPA; CAB034435; -.
DR   HPA; HPA063026; -.
DR   MIM; 604089; gene.
DR   neXtProt; NX_Q9UBK5; -.
DR   OpenTargets; ENSG00000126264; -.
DR   PharmGKB; PA134956649; -.
DR   eggNOG; ENOG410J782; Eukaryota.
DR   eggNOG; ENOG4111C1J; LUCA.
DR   GeneTree; ENSGT00390000012777; -.
DR   HOGENOM; HOG000112856; -.
DR   HOVERGEN; HBG106666; -.
DR   InParanoid; Q9UBK5; -.
DR   KO; K07988; -.
DR   OMA; HPGHILF; -.
DR   OrthoDB; \N; -.
DR   PhylomeDB; Q9UBK5; -.
DR   TreeFam; TF338335; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   ChiTaRS; HCST; human.
DR   GeneWiki; HCST_(gene); -.
DR   GenomeRNAi; 10870; -.
DR   PRO; PR:Q9UBK5; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000126264; -.
DR   CleanEx; HS_HCST; -.
DR   Genevisible; Q9UBK5; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; IDA:UniProtKB.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IGI:CACAO.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   InterPro; IPR009861; HCST.
DR   PANTHER; PTHR21409; PTHR21409; 1.
DR   Pfam; PF07213; DAP10; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disulfide bond; Glycoprotein;
KW   Membrane; Phosphoprotein; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19     93       Hematopoietic cell signal transducer.
FT                                /FTId=PRO_0000330287.
FT   TOPO_DOM     19     48       Extracellular. {ECO:0000255}.
FT   TRANSMEM     49     69       Helical. {ECO:0000255}.
FT   TOPO_DOM     70     93       Cytoplasmic. {ECO:0000255}.
FT   REGION       86     89       PIK3R1 binding site.
FT   REGION       86     88       GRB2 binding site.
FT   MOD_RES      86     86       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:16582911}.
FT   VAR_SEQ      81     81       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10426994,
FT                                ECO:0000303|PubMed:12975309}.
FT                                /FTId=VSP_033022.
FT   MUTAGEN      57     57       D->A: Abolishes stable interaction with
FT                                KLRK1. {ECO:0000269|PubMed:10426994}.
FT   MUTAGEN      88     88       N->Q: Abrogates cell killing and
FT                                interaction with GRB2. No effect on
FT                                interaction with PIK3R1.
FT                                {ECO:0000269|PubMed:16582911}.
FT   MUTAGEN      89     89       M->Q: Abrogates cell killing and
FT                                interaction with PIK3R1. No effect on
FT                                interaction with GRB2.
FT                                {ECO:0000269|PubMed:16582911}.
SQ   SEQUENCE   93 AA;  9489 MW;  97786F24F8A2EE44 CRC64;
     MIHLGHILFL LLLPVAAAQT TPGERSSLPA FYPGTSGSCS GCGSLSLPLL AGLVAADAVA
     SLLIVGAVFL CARPRRSPAQ EDGKVYINMP GRG
//
